Furthermore, the activation of the non-genomic pathway, via the combination of the epidermal growth factor receptor (EGFR) and AR, enhanced AR activity itself and modified the melanoma-associated antigen protein-A11 (MAGE-A11), improving melanoma proliferation [28]. Here, EGFR is linked to melanoma.